Research-grade follistatin pricing is primarily determined by synthesis methodology, recombinant expression system complexity, secondary purification steps, and batch-level analytical testing. Evaluating the true cost of follistatin requires examining high-performance liquid chromatography (HPLC) purity, mass spectrometry sequence confirmation, and endotoxin thresholds rather than comparing raw mass metrics alone.
Research-grade follistatin pricing is primarily determined by synthesis methodology, recombinant expression system complexity, secondary purification steps, and batch-level analytical testing. Evaluating the true cost of follistatin requires examining high-performance liquid chromatography (HPLC) purity, mass spectrometry sequence confirmation, and endotoxin thresholds rather than comparing raw mass metrics alone.
The catalog follistatin price for laboratory research typically spans a wide range based on isoform specification (such as FST-288, FST-300, or FST-315), biological expression host, and degree of downstream purification. High-purity recombinant follistatin optimized for cell culture or animal models commands a premium due to multi-step chromatography requirements and strict endotoxin limits (< 0.1 EU/µg). Evaluating cost requires balancing sequence integrity against analytical validation.
When procurement officers and principal investigators evaluate the overall cost structure of candidate peptides across all peptides, focus must remain on batch-to-batch consistency. Obtaining low-grade or unverified proteins often introduces experimental noise, confounding cellular assay parameters and ultimately wasting valuable laboratory resources. Purchasing through a verified US-based vendor ensures that every vial delivers the exact sequence, folding structure, and purity required for rigorous scientific inquiry.
Follistatin (FST) is an autocrine, cysteine-rich glycoprotein that acts as a potent high-affinity binding protein to specific members of the transforming growth factor-beta (TGF-β) superfamily. Discovered initially in follicular fluid, follistatin serves as an endogenous antagonist to activin A, activin B, and myostatin (growth differentiation factor 8, or GDF-8). In preclinical models, the neutralization of these ligands prevents them from engaging the activin type II receptor (ActRIIB), thereby altering downstream SMAD2/SMAD3 phosphorylation cascades.
The follistatin gene yields several distinct isoforms through alternative splicing and post-translational proteolysis. The primary full-length transcript encodes FST-315, a 315-amino acid precursor that circulates predominantly in systemic biofluids. Terminal cleavage can generate FST-288, a shorter, membrane-bound variant featuring an exposed basic heparin-binding domain that displays high affinity for cell-surface glycosaminoglycans. Another prevalent isoform, FST-300, exhibits intermediate tissue-binding dynamics. The specific isoform selection significantly influences both manufacturing complexity and the resulting follistatin research peptide valuation.
In vitro assays and preclinical rodent models frequently utilize recombinant follistatin to investigate tissue hypertrophy, anti-fibrotic activity, and cellular differentiation pathways. Because activin and myostatin act as negative regulators of skeletal muscle mass, systemic or localized administration of follistatin in animal models leads to marked increases in myofiber cross-sectional area. Preclinical studies suggest that by sequestering GDF-8 prior to receptor engagement, follistatin effectively disinhibits myoblast proliferation and protein translation pathways.
Beyond skeletal muscle physiology, researchers utilize follistatin to study reproductive endocrinology, renal fibrosis, and metabolic homeostasis. In vitro data indicate that follistatin modulates follicle-stimulating hormone (FSH) secretion from pituitary cells by binding activins with nanomolar affinity. Additionally, preclinical investigations into organ fibrosis demonstrate that local neutralization of TGF-β family ligands can attenuate extracellular matrix deposition. Comprehensive details on TGF-β superfamily signaling cascades are archived in our dedicated research library.
Unlike simple linear peptides produced via standard solid-phase peptide synthesis (SPPS), full-length follistatin is a highly structured, heavily disulfide-bonded glycoprotein. Producing functional, correctly folded follistatin requires complex eukaryotic or optimized prokaryotic recombinant expression systems, such as *Escherichia coli*, *CHO* (Chinese Hamster Ovary) cells, or *HEK293* human embryonic kidney lines. Expressing complex proteins in mammalian cell culture significantly increases media costs, bioreactor operation time, and yield management complexity compared to simple chemical synthesis.
Following cellular expression, the raw protein lysate must undergo multi-stage refolding protocols to form the correct intramolecular disulfide bridges required for biological activity. Refolding is followed by sequential chromatography steps, including affinity chromatography, ion-exchange chromatography, and reverse-phase high-performance liquid chromatography (RP-HPLC). Each additional purification cycle reduces overall milligram yield while increasing final purity, directly driving the final catalog price for research-grade material.
To ensure experimental validity, researchers should strictly avoid unverified suppliers offering discounted compounds without batch-specific documentation. Price points should always be evaluated alongside comprehensive analytical testing. At PX1 Research, every production lot undergoes rigorous quality control within an ISO 17025 accredited laboratory environment to verify identity, purity, and safety profiles.
Primary analytical standards for research-grade follistatin include:
1. Reverse-Phase HPLC (RP-HPLC): Establishes chemical purity, confirming that the target protein constitutes ≥98% of the total peptide content without minor truncated or degraded fragments. 2. Electrospray Ionization Mass Spectrometry (ESI-MS): Confirms exact molecular mass, verifying correct amino acid sequencing and the absence of sequence mutations. 3. Endotoxin Assay (LAL Test): Quantifies bacterial lipopolysaccharide levels to ensure concentrations remain strictly below <0.1 EU/µg, preventing endotoxin-induced inflammatory confounding in cell culture or animal studies. 4. Lot-Specific Certificate of Analysis (COA): Fully transparent documentation detailing raw chromatograms and mass spectra provided with every order.
When designing preclinical investigations into hyperplastic, hypertrophic, or metabolic signaling pathways, investigators often compare follistatin against other targeted growth factors and regulatory peptides. The choice between these compounds depends on whether the study protocol calls for direct receptor agonism, ligand sequestration, or downstream secretagogue activity.
For example, researchers exploring muscle hypertrophy mechanisms might evaluate follistatin alongside IGF-1 LR3, a long-acting analog of insulin-like growth factor 1 that acts directly on the IGF-1 receptor pathway. Alternatively, protocols focusing on upstream growth hormone modulation may utilize secretagogues such as CJC-1295 No DAC or investigate localized tissue repair mechanisms using BPC-157. While secretagogues and short linear peptides are synthesized via SPPS at a lower production cost per milligram, recombinant glycoproteins like follistatin require significantly more complex expression and purification infrastructure, establishing a higher base price point.
To preserve protein stability and biological activity upon receipt, research facilities must adhere to standardized handling protocols. Lyophilized follistatin should be stored at -20°C or -80°C in a desiccated environment away from light. Prior to reconstituting, the vial should be allowed to equilibrate to room temperature to prevent condensation inside the container.
Reconstitution should be performed using sterile, endotoxin-free water or phosphate-buffered saline (PBS, pH 7.4). For long-term storage of reconstituted stock solutions, adding a carrier protein such as 0.1% Bovine Serum Albumin (BSA) or Human Serum Albumin (HSA) helps prevent non-specific protein adsorption to polypropylene tube walls. Reconstituted aliquots must be flash-frozen and kept at -80°C, avoiding repeated freeze-thaw cycles that induce protein denaturation and aggregation. Detailed reconstitution charts are available in our reconstitution guide.
For academic institutions, contract research organizations (CROs), and biotechnology firms conducting large-scale preclinical studies, sourcing follistatin through structured procurement channels reduces overall expenditure. PX1 Research offers flexible options via our wholesale portal for high-volume research requirements, providing tiered pricing structures that optimize grant funding without compromising quality standards.
All PX1 Research products are manufactured in the USA within GMP-compliant facilities. Orders are dispatched with same-day shipping (Monday through Friday) directly from our distribution hubs in California and Arizona. Fast, temperature-monitored supply chains ensure that sensitive recombinant proteins arrive at your laboratory with uncompromised biological activity.
Why does the price of research-grade follistatin vary so significantly between vendors?
Pricing variations reflect differences in synthesis methodology (recombinant mammalian or bacterial expression vs. synthetic), purification thoroughness (RP-HPLC steps), endotoxin testing protocols, and batch-specific analytical validation. Lower-priced offerings often lack verified COAs or exhibit high endotoxin levels that can invalidate cell culture experiments.
What is the difference between FST-288 and FST-315 in laboratory research?
FST-288 is a shorter isoform containing an exposed basic heparin-binding domain, causing it to bind rapidly to tissue cell surfaces. FST-315 is the full-length, naturally circulating isoform with lower cell-membrane affinity, allowing broader systemic distribution in animal models.
How does PX1 Research verify the purity of its follistatin orders?
PX1 Research utilizes an independent ISO 17025 accredited laboratory to perform Reverse-Phase HPLC for purity quantification (ensuring ≥98% purity), Mass Spectrometry (ESI-MS) for molecular weight verification, and LAL assays to ensure endotoxin levels remain below 0.1 EU/µg.
What is the recommended storage temperature for lyophilized follistatin?
Lyophilized follistatin should be stored at -20°C or -80°C upon delivery. Under these conditions, the desiccated protein remains stable for up to 24 months.
Can reconstituted follistatin be refrozen multiple times?
No. Repeated freeze-thaw cycles cause physical stress that denatures recombinant proteins and promotes irreversible aggregation. Reconstituted stock solutions should be divided into single-use aliquots and stored at -80°C.
Is PX1 Research follistatin intended for human administration?
No. All products supplied by PX1 Research are strictly for in vitro, cell culture, and preclinical laboratory research use only. They are not for human or animal therapeutic, diagnostic, or clinical use.
Does PX1 Research offer institutional discounts for bulk research purchases?
Yes. Qualified academic laboratories, CROs, and institutional procurement officers can access bulk volume pricing by contacting us through our dedicated wholesale portal.
Where are PX1 Research compounds manufactured and shipped from?
All research compounds are manufactured in US-based GMP-compliant facilities and shipped directly from our primary fulfillment centers located in California and Arizona, with same-day dispatch available Monday through Friday.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.